Folge 23 – Andrew Dudum: Gründer und CEO von Hims & Hers

HIMS Stock is Fire - But why?

HIMS Stock Is About to Explode — Here's What Everyone Is Missing

Is HIMS Stock Really Going to $145? (The Truth)

Hims & Hers: Ein Fallendes Messer oder Die Beste Gelegenheit des Jahres?

HIMS Review: Erectile Dysfunction Treatment Without the Doctor Visit?

Bijan Salehizadeh – Retatrutid, Peptide, Hims gegen Ro und Lillys Krieg gegen zusammengesetzte GL...

HIMS STOCK UPDATE 💥 FTC LAWSUIT + $75,000 FINES FROM VISA

How Hims & Hers Reached a $4.3BN Market Cap on $2.3BN of Revenue | Andrew Dudum

HIMS & HERS AKTIE: Die Ruhe vor dem Sturm! 💥 Chart Update

HIMS + Oscar Health: This Changes Everything?

Dumpster Fire Prices! HIMS, CELH, & MARA Deeply Discounted Despite Recent Catalysts... (Too Cheap!)

Hims Stock Is So Cheap & The Market Has No Idea! From 27 to 19 in 2 weeks—All Novo Gains Are Gone..

Hims Stock +7% on Insider Buy! This Volatile Stock Is Still Too Cheap.. + Latest CEO Interview Takes

Hims & Hers Stock: Is HIMS a Buy After $32 Target?

Hims Officially Launches Wegovy Pill & Branded GLP-1s with Novo! The Stock Has to Be Up...Right? No!

The Biggest Opportunity Yet | HIMS Stock Analysis

Hims Stock: Latest CEO Interview Recap—Labs, GLP1s, Big Tech, 10x Better, Ads, AI, Scale & Peptides!

Hims Stock RAISES 2026 OUTLOOK! Sandbag King! Huge GLP-1 Momentum, Global Sales 10xd...OC We're Down

Hims & Hers CEO: We deliver health care at prices that are ‘cheaper than insurance’

Hims & Hers Aktie - Was jetzt? Struktur entscheidet über Fahrplan | Elliott Wellen Analyse

$HIMS Hims & Hers Health Ergebnis-Telefonkonferenz für das 2. Quartal 2026

Hims & Hers Stock Analysis: Why This 30% Short Interest Is So Dangerous

Hims & Hers Stock Analysis: Is HIMS About to Make a Massive Comeback?

FTC LAWSUIT AGAINST HIMS! 😱 IS THIS THE END?

Hims Stock Down on Outstanding Execution: Eucalyptus Deal Closes WAY early! Outlook TOO SANDBAGGED!

Hedgefonds-Manager Imran Khan kaufte Hims in der Phase der größten Ablehnung nach – hier ist der ...

HIMS STOCK CRASHING AFTER EARNINGS 😱 IS IT TIME TO BUY?

Hims Stock Has a Losing Week on New "Peptide FUD" - Is the Stock Still TOO CHEAP!?

HIMS-Aktie stürzt ab... (Hier ist der Grund) | HIMS Aktienanalyse

Why Hims & Hers Stock Is Falling Despite 38.2% Revenue Growth! | HIMS Stock Analysis

Angst vs. Chance: Ist HIMS der nächste große Gewinner?

Besitzen Sie HIMS-Aktien? Dann machen Sie sich bereit! 🚀

Hims Stock Surges +8% to $35 on GLP-1 Frenzy! Is Hims Still Cheap? New Catalysts (Peptides, Outlook)

HIMS Stock Analysis Can HIMS Break $30 Next? $40 Target Still Possible? EP. 394 #HIMS #HIMSStock

Hims & Hers Aktie Chartanalyse